How big is the China Active Pharmaceutical Ingredients Market?

The China Active Pharmaceutical Ingredients Market size is expected to reach USD 14.81 billion in 2024 and grow at a CAGR of 7.86% to reach USD 21.62 billion by 2029. Read More

What is the current China Active Pharmaceutical Ingredients Market size?

In 2024, the China Active Pharmaceutical Ingredients Market size is expected to reach USD 14.81 billion. Read More

Who are the key players in China Active Pharmaceutical Ingredients Market?

CSPC Pharmaceutical Group Limited (Shijiazhuang Pharmaceutical Group Co., Ltd), WuXi AppTec (WuXi STA), Lonza, Reyoung Pharmaceuticals and Sandoz Group AG are the major companies operating in the China Active Pharmaceutical Ingredients Market. Read More

What years does this China Active Pharmaceutical Ingredients Market cover, and what was the market size in 2023?

In 2023, the China Active Pharmaceutical Ingredients Market size was estimated at USD 13.65 billion. The report covers the China Active Pharmaceutical Ingredients Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the China Active Pharmaceutical Ingredients Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the major factors driving the China Active Pharmaceutical Ingredients (API) Market?

The major factors driving the China Active Pharmaceutical Ingredients (API) Market are a) Increasing focus on API quality and regulatory compliance b) Growing advancements in technology and process efficiency Read More

What are the major factors driving the China Active Pharmaceutical Ingredients (API) Market?

The major factors driving the China Active Pharmaceutical Ingredients (API) Market are a) Increasing focus on API quality and regulatory compliance b) Growing advancements in technology and process efficiency Read More

China Active Pharmaceutical Ingredients (API) Market Share

Statistics for the 2023 & 2024 China Active Pharmaceutical Ingredients (API) market share, created by Mordor Intelligence™ Industry Reports. China Active Pharmaceutical Ingredients (API) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

~~$4750~~

Team License

~~$5250~~

Corporate License

~~$8750~~

Buy Now

Book before:

Market Share of China Active Pharmaceutical Ingredients (API) Industry

The Chinese active pharmaceutical ingredients market is relatively fragmented. The API market has several manufacturers focusing on expanding their footprints by adopting various business strategies, such as collaborations, facility expansion, and drug approvals. Some key market players include CSPC Pharmaceutical Group Limited (Shijiazhuang Pharmaceutical Group Co. Ltd), WuXi AppTec (WuXi STA), and Lonza.

China Active Pharmaceutical Ingredients (API) Market Leaders

CSPC Pharmaceutical Group Limited (Shijiazhuang Pharmaceutical Group Co., Ltd)
WuXi AppTec (WuXi STA)
Lonza
Reyoung Pharmaceuticals
Sandoz Group AG

*Disclaimer: Major Players sorted in no particular order

China Active Pharmaceutical Ingredients (API) Market Share

Market Share of China Active Pharmaceutical Ingredients (API) Industry

China Active Pharmaceutical Ingredients (API) Market Leaders

China Active Pharmaceutical Ingredients (API) Market Report Snapshots

China Active Pharmaceutical Ingredients (api) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)